Surgeons, PAs, surgical assistants, techs, nurses, OR leaders — you each see a different angle of the same room. We're building the next generation of surgical tools, and we want to hear from the people whose hands are actually in the work. Five quick questions to start.
No wrong answers. This helps us understand who we're hearing from and where the friction lives across different roles.
Please answer the required questions before continuing.
You're exactly who we're looking for
Your experience puts you right at the center of what we're building. What comes next is confidential, in-development work — the kind we only share with the people closest to the problem. A few quick questions first, then we'll show you what we've been working on.
Rate it from where you stand. This tells us how the pain actually shows up — and how often.
Please answer the required questions before continuing.
What we're building first lives in GYN — but HouserLogics is built to bring OR ideas to life, whatever the specialty. So before you go: tell us what YOU wish someone would build. Then ride along with us and watch it happen — you'll be first to know as we grow, and your idea could be the one we pick up next.
Please enter a valid email so we can keep you updated.
A hard truth most rooms have stopped noticing
The uterus has to be positioned precisely for every critical step — and you're trusting that to verbal direction and another set of hands. These aren't rare edge cases. They're documented, recurring, and tied to how the uterus is handled. Read them with your own cases in mind.
In a survey of gyn surgeons, 87.2% reported it — and one cancer series put the per-case rate at 11%, changing adjuvant therapy in nearly a quarter of those cases.
Segura et al., Gynecol Oncol 2021 · MIS endometrial cancer, 2023The ureter sits millimeters from the field at colpotomy. In 1 in 8 patients it runs within 5 mm of the lateral cervix — closer than the instrument in your hand.
Abdel Khalek, Updates Surg 2020 · Contemporary OB/GYN 2025A 2025 clinical opinion names the core problem outright: assistant-operated manipulation introduces “variability, communication delays, and limitations to surgeon autonomy.” 94% wanted surgeon-direct control.
Surgeon-controlled manipulator opinion, IJGO 2025The device literature states it plainly: adjusting the uterus “by directly applying force… through communication with a main operator… delays surgery time and deteriorates accuracy.”
Uterine manipulator patent disclosuresThe one tool positioning the organ you're operating on is handed to an assistant at the foot of the bed, reacting to verbal cues — while the outcome stays entirely on you.
Surgeon-autonomy & OR-communication literatureContinuous cephalad pressure is held by an assistant for the length of the case. Skill and fatigue introduce variability into the one thing that needs to stay rock-steady.
SLH vaginal-assistant guidance · manipulator-robotics reviewsRepositioning by pressing the handle against vaginal tissue “may cause substantial injury,” and a static cup can't adapt to anatomy — so the surgeon resects to the cup, not to the patient.
Manipulator patent lit · Misirlioglu et al., JTGGAThe cutting line is inferred from cup-edge feel and experience — not a live, visible landmark. Exposure depends entirely on how well the uterus is held at exactly the right moment.
Colpotomy technique reviews, ScienceDirectCurved-handle ante/retroversion is “extremely limited.” In fibroids, dense adhesions, deep endo, and the obliterated cul-de-sac — exactly when you need the most — manual manipulation runs out of reach and force.
Manipulator patent lit · difficult-hysterectomy literatureEvery one of these traces back to the same things: how the uterus is held and positioned, and how cleanly the colpotomy is made. If any of these felt familiar, you already know why we're building. Tell us where your experience lines up.
Answer based on your role, your current devices, and your workflow. Some questions won't apply to every position — just mark those N/A. We want the unfiltered version from your seat in the room.
Please answer the required questions before continuing.
What follows is pre-patent and not yet FDA cleared — confidential development work. To protect it while we're still in this stage, we ask everyone who previews it to agree to a brief, standard confidentiality agreement. No redirect, no account — just read and sign below.
This Mutual Confidentiality & Non-Disclosure Agreement ("Agreement") is entered into as of the date of electronic signature below ("Effective Date") between HouserLogics LLC, a Florida limited liability company ("HouserLogics"), and the individual identified by the electronic signature below ("Recipient"). HouserLogics and Recipient are each a "Party" and together the "Parties." Because HouserLogics is the Party disclosing confidential information in this exchange, Recipient's obligations are the primary focus of this Agreement; however, any confidential information Recipient discloses to HouserLogics is afforded the same protections.
HouserLogics wishes to share certain confidential information with Recipient for the sole purpose of allowing Recipient to review early-stage surgical device concepts and provide feedback (the "Purpose"). This Agreement governs that disclosure.
"Confidential Information" means any non-public information disclosed by HouserLogics to Recipient, in any form (visual, oral, written, electronic, or by inspection of tangible objects), that is either marked or identified as confidential or that a reasonable person would understand to be confidential given its nature or the circumstances of disclosure. Confidential Information includes, without limitation: device designs, mechanisms, structures, and architecture; prototypes, samples, and models; drawings, CAD files, schematics, and specifications; methods, techniques, and processes; patent-pending and unpatented inventions; research, test data, and clinical observations; business, marketing, financial, and commercialization plans; pricing; supplier and customer information; and the existence and content of the Parties' discussions.
Recipient shall: (a) hold all Confidential Information in strict confidence and protect it with at least the same degree of care it uses for its own confidential information, and no less than a reasonable degree of care; (b) not disclose Confidential Information to any third party without HouserLogics' prior written consent; (c) use Confidential Information solely for the Purpose and for no other purpose; (d) not copy, photograph, screenshot, record, or otherwise reproduce the Confidential Information; (e) not reverse engineer, disassemble, or attempt to derive the design, structure, or underlying ideas of any prototype, device, or material disclosed; and (f) not use the Confidential Information to compete with HouserLogics or to diminish the proprietary value of the Confidential Information.
Confidential Information does not include information that Recipient can demonstrate by competent written evidence: (a) is or becomes publicly available through no act or omission of Recipient; (b) was rightfully known to Recipient, without obligation of confidentiality, prior to disclosure by HouserLogics; (c) is rightfully received from a third party without obligation of confidentiality; or (d) is independently developed by Recipient without use of or reference to the Confidential Information.
If Recipient is required by law, regulation, or valid court order to disclose Confidential Information, Recipient shall, to the extent legally permitted, give HouserLogics prompt prior written notice so that HouserLogics may seek a protective order, and shall disclose only the portion legally required.
All Confidential Information remains the sole property of HouserLogics. Nothing in this Agreement grants Recipient any license, right, title, or interest in or to the Confidential Information or any patent, copyright, trademark, trade secret, or other intellectual property right of HouserLogics, whether by implication, estoppel, or otherwise.
Upon HouserLogics' written request, upon termination of the Parties' discussions, or upon expiration of this Agreement, Recipient shall promptly return or destroy (and, if requested, certify the destruction of) all Confidential Information and all copies, notes, and materials derived from it.
This Agreement takes effect on the Effective Date and remains in force for three (3) years thereafter. Recipient's obligations of confidentiality survive expiration and continue for so long as the Confidential Information remains non-public, and obligations with respect to any information constituting a trade secret continue for so long as such information remains a trade secret under applicable law.
Recipient acknowledges that unauthorized disclosure or use of Confidential Information would cause HouserLogics irreparable harm for which monetary damages would be an inadequate remedy. Accordingly, HouserLogics is entitled to seek injunctive and other equitable relief, without the necessity of posting a bond, in addition to any other remedies available at law or in equity, including recovery of damages.
Nothing in this Agreement obligates either Party to proceed with any transaction or relationship. Confidential Information is provided "as is," without warranty of any kind as to accuracy or completeness.
This Agreement is governed by the laws of the State of Florida, without regard to its conflict-of-laws principles. The Parties consent to the exclusive jurisdiction and venue of the state and federal courts located in Palm Beach County, Florida for any dispute arising under this Agreement.
(a) Severability. If any provision is held unenforceable, the remaining provisions remain in full force, and the unenforceable provision shall be modified to the minimum extent necessary to make it enforceable. (b) No Waiver. Failure to enforce any provision is not a waiver of the right to enforce it later. (c) Entire Agreement. This Agreement is the complete and exclusive agreement between the Parties regarding its subject matter and supersedes all prior or contemporaneous understandings. (d) Amendment. Any amendment must be in writing. (e) Electronic Signature. The Parties agree this Agreement may be executed electronically, and that Recipient's typed name together with the affirmative actions below constitute a valid electronic signature with the same legal force and effect as a handwritten signature under the U.S. ESIGN Act and applicable state law.
A record of your agreement — your typed signature, the date and time, and the agreement version — is retained with your response as proof of execution. You may request a copy or paper version at any time by contacting HouserLogics. This is a standard early-stage confidentiality agreement.
Thank you for signing. Each piece below is in active development — engineering underway, coming together toward one integrated system. As you look, keep your own cases in mind: we'll ask what you think on the next screen.
This is the part that shapes the product. Be candid; critical feedback is more valuable to us than polite feedback.
Please answer the required questions before submitting.
Your experience and your reaction are now part of the research that decides what we build. The people in the room — surgeons, assistants, techs, and nurses alike — are the reason this gets built right.
— The HouserLogics team
Utero-Flex by HouserLogics LLC · Confidential pre-market research · Not for distribution
You're now part of the HouserLogics circle. We'll keep you posted as we build — and the moment something lands in your corner of the OR, you'll be among the first to hear. The future of surgery gets built by people like you.
— The HouserLogics team
HouserLogics LLC · Building the next generation of surgical tools · Confidential research